Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05126810 · ClinicalTrials.gov registry record
Willingness to Participate in a Trial Comparing Standard Genetic Counseling Versus Personalized Genetic Counseling
A clinical trial of Li-Fraumeni Syndrome, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT05126810 is a study of Li-Fraumeni Syndrome that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 500 participants, below the 1,993-participant average among 6 other Li-Fraumeni Syndrome trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05126810, a study of Li-Fraumeni Syndrome, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates patients willingness to participate in a trial comparing standard genetic counseling versus personalized genetic counseling. Collecting information from patients may help researchers learn why patients may or may not take part in the future study that compares standard genetic counseling to personalized genetic counseling.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2022-11-03 |
| Est. Completion | 2027-10-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05126810
The ClinicalTrials.gov registry entry for NCT05126810 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,993-participant average among 6 other Li-Fraumeni Syndrome trials with a reported enrollment target (75% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Li-Fraumeni Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Questionnaire Administration is the first listed.
NCT05126810 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05126810 about?
NCT05126810 is a clinical study titled "Willingness to Participate in a Trial Comparing Standard Genetic Counseling Versus Personalized Genetic Counseling". This study evaluates patients willingness to participate in a trial comparing standard genetic counseling versus personalized genetic counseling. Collecting information from patients may help researchers learn why patients may or may not take part in the future study that compares standard genetic c...
What is the current status of trial NCT05126810?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2022-11-03. Estimated completion is 2027-10-02.
What conditions does trial NCT05126810 study?
This clinical trial studies the following conditions: Li-Fraumeni Syndrome.
What interventions are being tested in trial NCT05126810?
The interventions under investigation include: Questionnaire Administration (OTHER).
Who is sponsoring clinical trial NCT05126810?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05126810 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Li-Fraumeni Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
RECRUITING
-
Clinical and Genetic Studies of Li-Fraumeni Syndrome
RECRUITING
-
Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress
RECRUITING
-
Li-Fraumeni Syndrome/TP53 Biobank
RECRUITING
-
Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes
ACTIVE NOT RECRUITING · NA
-
Exploring How to Adapt an Evidence-Based Mindful Self-Compassion Program for Young Adults With Li-Fraumeni Syndrome
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.